Giving 2000 IU of vitamin D3 daily to obese children with low vitamin D levels slightly reduces their waist size and body fat, but doesn't change their overall weight or muscle mass.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis would determine whether the observed reduction in waist circumference and fat mass is consistent across studies and whether it is clinically meaningful for metabolic risk reduction.
A systematic review and meta-analysis of all RCTs in children aged 10–18 with serum 25(OH)D <20 ng/mL and BMI ≥85th percentile, comparing vitamin D3 doses ≥2000 IU/day versus ≤600 IU/day for ≥6 months, with waist circumference and total body fat (DXA) as primary outcomes.
A larger RCT with multiplicity adjustment would confirm whether vitamin D3 specifically reduces abdominal fat mass independent of diet or activity.
A double-blind RCT with 500+ vitamin D-deficient obese children aged 10–18, randomized to 2000 IU/day vitamin D3, 1000 IU/day, or placebo for 12 months, with waist circumference and total body fat (DXA) as primary outcomes, controlling for diet, physical activity, and puberty, with multiplicity adjustment.
A prospective cohort would determine whether higher vitamin D levels predict slower accumulation of abdominal fat over time in obese children.
A prospective cohort following 1000 vitamin D-deficient obese children aged 10–12 for 7 years, with annual vitamin D3 supplementation (2000 IU/day) or no supplementation, measuring annual waist circumference, DXA body fat, and serum 25(OH)D, adjusting for diet, activity, and puberty.
A case-control study could compare past vitamin D levels in children with high versus low abdominal fat mass.
A case-control study comparing 150 obese children aged 14–18 with waist circumference ≥90th percentile to 150 matched controls with waist circumference <75th percentile, retrospectively assessing serum 25(OH)D levels and supplementation history from ages 10–13, adjusting for BMI and race.
A cross-sectional study could identify whether higher serum 25(OH)D levels correlate with lower waist circumference or body fat at a single point in time.
A cross-sectional survey of 1500 obese children aged 10–18 measuring serum 25(OH)D, waist circumference, and total body fat (DXA) simultaneously, adjusting for race, BMI, season, and physical activity.